AIDS2026: Is HIV remission the new cure?
By Heather Ellis This article was originally published in Positive Living. Set against Rio’s flamboyant backdrop of strong activism, AIDS2026
HIV
HIV Cure Research: A discrete choice experiment
Your thoughts can help shape how future HIV cure trials and cure treatments are designed – making them safer, more ethical, and more community-friendly.
Reversing latent HIV with mRNA and lipid nanoparticles: A promising new strategy
By Bridget Fisher and Dr Michael Moso Latent HIV that remains ‘silent’ in CD4 T cells is a major barrier
Time to HIV viral rebound and post-treatment controller in HIV cure studies with treatment interruptions
By Dr Jesper D Gunst, Dr Jesal Gohil, Dr Ole S Sogaard, Dr Sarah Fidler Researchers from Denmark and The
Unpacking the HIV science at AIDS2024
With an HIV cure more elusive than ever, Heather Ellis finds that HIV scientists have turned their attention to innovative ‘nano-formulation’ strategies. By attending AIDS2024 from the comfort of home, she discovered how they plan to out-smart HIV in hiding and develop more effective treatments that will hopefully reduce the HIV reservoir and therefore low-level inflammation.
Hidden, but not forgotten: Understanding HIV hiding in the brain
Antiretroviral treatment (ART) has significant benefits for the health and quality of life of people with HIV. Despite this, a
New sequencing method shows many blood-derived HIV particles are defective
Sydney researchers have developed a way to sequence near-full-length HIV-genomes from viral particles in the blood. This new test is
High CD4 count before HIV treatment contributes to smaller HIV reservoir on ART
Researchers found that people infected with HIV who maintained a CD4+ count during untreated infection as high as that in
Maintaining momentum: HIV cure research in the COVID era
The COVID-19 pandemic has devastated lives, healthcare systems and economies around the world. Research has not escaped unscathed. Clinical trials
HIV cure snapshot
The Australasian HIV&AIDS Conference (commonly known as ASHM after the organiser, the Australasian Society for HIV Medicine) was held online
Towards Meaningful Engagement in Melbourne
Background In 2018, the Victorian Government Department of Health and Human Services announced $1.2 million funding to establish the Melbourne
Block and lock: a pathway to remission
‘Block and lock’ is an emerging option in the pursuit of an HIV cure. Kirby Institute researchers have developed an